The Biomedical Engineering Society (BMES) highlights Dr. Raimondo’s research using LNPs to target Natural Killer cells for Cancer Immunotherapy. You can read the Special Delivery article here.
- Raimondo Lab presents at the 2024 BMES Annual Meeting
- Raimondo Lab wins poster award at the 2025 CMBE conference